Evidence for progesterone receptors in the human fetoplacental vascular tree

Biology of Reproduction

Volumn 62, Issue 3, 2000, Pages 759-765

  Cudeville, Corinne ^a   Mondon, Françoise ^a   Robert, Brigitte ^a   Rebourcet, Régis ^a   Mignot, Thérèse Marie ^a   Benassayag, Claudine ^a   Ferré, Françoise ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR; PROMEGESTONE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENDOTHELIUM CELL; FEMALE; FETOPLACENTAL UNIT; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 0034003651     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod62.3.759     Document Type: Article

References (50)

1. Poston L, McCarthy AL, Ritter JM. Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Thcr 1995; 65:215-239.
2. Boura ALA, Walter WAW, Read MA, Leicht IM. Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol 1994; 21:737-748.
3. Kalenga MK, de Gasparo M, Thomas K, de Hertog R. Angiotensin II and its different receptor subtypes in placenta and fetal membranes. Placenta 1996; 17:103-110.
4. 125I] endothelin-1 binding sites on trophoblast and blood vessels of human placenta. J Clin Endocrinol Metab 1993; 76:237-244.
5. Bourgeois C, Robert B, Rebourcet R, Mondon F, Mignot TM, Duc-Goiran P, Ferré F. Endothelin-1 and ETA receptor expression in vascular smooth muscle cells from human placenta: a new ETA receptor messenger ribonucleic acid is generated by alternative splicing of exon 3. J Clin Endocrinol Metab 1997; 82:3116-3123.
6. Sabry S, Mondon F, Levy M, Ferré F, Dinh-Xuan AT. Endothelial modulation of vasoconstrictor responses to endothelin-1 in human placental stem villi small arteries. Br J Pharmacol 1995; 115:1038-1042.
7. Myatt L, Brockman DE, Eis AL, Pollock JS. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 1993; 14:487-495.
8. Maggi M, Vannelli GB, Peri A, Brandi ML, Fantoni G, Giannini S, Torrisi C, Guardabasso V, Barni T, Toscano V, Massi V, Serio M. Immunolocalization, binding and biological activity of endothelin in rabbit uterus: effect of ovarian steroids. Am J Physiol 1991; 260:292-305.
9. Morey AK, Pedram A, Razandi M, Prins BA, Ren-Ming Hu, Beisiada E, Levin ER. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 1997; 138:3330-3337.
10. 2+ homeostasis in human myometrial smooth muscle cells. Am J Physiol 1999; 276:379-385.
11. Dave S, Farrance DP, Whitehead SA. Evidence that nitric oxide inhibits steroidogenesis in cultured rat granulosa cells. Clin Sci 1997; 92:277-284.
12. Mignot TM, Mallassiné A, Cronier L, Ferré F. Endothelin increases progesterone release by human trophoblast in culture. In: Baldi E, Maggi M, Cameron IT, Dunn MJ (eds.), Endothelin in Endocrinology: New Advances. Frontiers in Endocrinology, Vol. 15: Ares-Serono Symposia Publications; 1995: 277-283.
13. Ferré F. Molecular mechanisms of parturition. Infect Dis Obstet Gynecol 1997; 5:98-105.
14. Bergqvist A, Bergqvist D, Ferno M. Estrogen and progesterone receptors in vessel walls. Acta Obstet Gynecol Scand 1993 72:10-16.
15. Omar HA, Ramirez R, Gibson M. Properties of a progesterone-induced relaxation in human placental arteries and veins. J Clin Endocrinol Metab 1995; 80:370-373.
16. Morey AK, Razandi M, Pedram A, Hu RM, Prins BA, Levin ER. Oestrogen and progesterone inhibit the stimulated production of endothelin-1. Biochem J 1998; 330:1097-1105.
17. Perrot-Applanat M, Deng M, Fernandez H, Lelaidier C, Meduri G, Bouchard P. Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: expression in endometrial blood vessels. J Clin Endocrinol Metab 1994; 78:216-224.
18. Perrot-Applanat M, Cohen-Solal K, Milgrom E, Finet M. Progesterone receptor expression in human saphenous veins. Circulation 1995; 92: 2975-2983.
19. Younes MA, Besch NF, Besch PK. Estradiol and progesterone binding in human term placental cytosol. Am J Obstet Gynecol 1981; 141: 170-174.
20. Padayachi T, Pegorato RJ, Hofmeyr J, Joubert SM, Norman RJ. Decreased concentrations and affinities of oestrogen and progesterone receptors of intrauterine tissue in human pregnancy. J Steroid Biochem 1987; 26:473-479.
21. Rivera J, Cano A. Oestrogen and progesterone receptors in human term placenta. Measurement by binding assays and immunological methods. Placenta 1989; 10:579-588.
22. McCormick PD, Razel AJ, Spelsberg TC, Coulam CB. Absence of high-affinity binding of progesterone (R5020) in human placenta and fetal membranes. Placenta 1981; 3(suppl): 123-132.
23. Roussev RG, Higgins NG, McIntyre JA. Phenotypic characterization of normal human placental mononuclear cells. J Reprod Immunol 1993; 25:15-29.
24. Wang JD, Zhu JB, Shi WL, Zhu PD. Immunocytochemical colocalization of progesterone receptor and prolactin in individual stromal cells of human decidua. J Clin Endocrinol Melab 1994; 79:293-307.
25. Patricio B. Estrogen and progesterone receptors in the human placenta. Rev Fr Gynecol Obstet 1994; 89:145-147.
26. Taddei G, Noci I, Periti E, Borri P, Torricelli F, Tozzi P, Moncini D, Paglierani M, Branconi F. Chorion villosum does not express progesterone and estrogen receptors during the first trimester of pregnancy. Gynecol Obstet Invest 1996; 42:77-79.
27. Gopi Shanker Y, Sharma SC, Jagannadha Rao A. Expression of progesterone receptors mRNA in the first trimester human placenta. Biochem Mol Biol Int 1997; 42:1235-1240.
28. Khan-Dawood FS, Dawood MY. Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy. Am J Obstet Gynecol 1984; 150:501-505.
29. Rossmanith WG,Wolfahrt S, Ecker A, Eberhardt E. The demonstration of progesterone, but not of estrogen, receptors in the developing human placenta. Horm Metab Res 1997; 29:604-610.
30. Libby P, O'Brien KV. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol 1983; 115:217-223.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
32. Misrahi M, Atger M, Auriol L. Complete sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun 1987; 143:740-748.
33. Robert B, Malassiné A, Bourgeois C, Mignot TM, Cronier L, Ferré F, Duc-Goiran P. Expression of endothelin precursor genes in human trophoblast in culture. Eur J Endocrinol 1996; 134:490-496.
34. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:247-248.
35. Dawood MY, Helmkamp F. Human umbilical arterial and venous progesterone concentrations: effect of fetal sex, weight and mode of delivery. Obstet Gynecol 1977; 50:450-455.
36. Shaxted EJ, Maynard PV. Plasma progesterone in the umbilical vessels at term an overview. Br J Obstet Gynaecol 1983; 90:801-810.
37. Aisien AO, Towobola OA, Otubu JAM, Imade GE. Umbilical cord venous progesterone at term delivery in relation to mode of delivery. Im J Gynecol Obstet 1994; 47:27-31.
38. Perrot-Applanat M, Groyer-Picard MT, Garcia E, Lorenzo F, Milgrom E. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology 1988; 123:1511-1519.
39. McGill HC Jr, Sheridan PJ. Nuclear uptake of sex steroid hormones in the cardiovascular system of the baboon. Circ Res 1981; 48:238-244.
40. Wang Jd, Zhu Jb, Fu Y Shi WI, Qiao Gm, Wang Yq, Chen J, Zhu Pd. Progesterone receptor immunoreactivity at the materno-fetal interface of first trimester pregnancy: a study of the trophoblast population. Hum Reprod 1996; 11:413-419.
41. Mabry White M, Zamudio S, Stevens T, Tyler R, Lindenfeld J, Leslie K, Moore LG. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev 1995; 16:739-751.
42. Jiang CW, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur J Pharmacol 1992; 211:163-167.
43. Wehling M. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 1997; 59:365-393.
44. Revelli A, Massobrio M, Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev 1998; 19:3-17.
45. Lee WS, Harder JA, Yoshizumi M, Lee ME, Haber E. Progesterone inhibits arterial smooth muscle cell proliferation. Nat Med 1997; 3: 1005-1008.
46. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990; 9:1603-1614.
47. Cavaillé F, Kacémi A, Mondon F, Fournier T, Ferré F. Contractile proteins in human fetoplacental vessels. Am J Obstet Gynecol 1995; 173:1793-1799.
48. Tulenko TN. Regional sensitivity to vasoactive polypeptides in human umbilico-placental vasculature. Am J Obstet Gynecol 1979; 135:629-636.
49. Allen J, Forman A, Maigard S, Jespersen LT, Anderson KE. Effect of endogenous vasoconstrictors on maternal intramyometrial and fetal stem villous arteries in pre-eclampsia. J Hypertens 1989; 7:529-536.
50. Myatt L. Current topic: control of vascular resistance in the human placenta. Placenta 1992; 13:329-341.